Skip to main content
. 2022 Sep 20;61(45):e202204955. doi: 10.1002/anie.202204955

Figure 1.

Figure 1

PET radio‐antibiotics evaluated as infection imaging agents and their respective cellular targets. Abbreviated content: G+: Gram‐positive specific; M: Mycobacteria‐specific; B: broad spectrum; FQL: fluoroquinolones; TMP: trimethoprim; INH: isoniazid (including PT70 and PT119); PZA: pyrazinamide; RIF: rifampin; LNZ: linezolid; BDQ: bedaquiline; ERM: erythromycin; DHFR: dihydrofolate reductase; KatG: mycobacterial catalase–peroxidase; InhA: enoyl‐ACP reductase; FAS II: type II fatty acid synthase system; Pzase: pyrazinamidase; PanD: aspartate 1‐decarboxylase; PABA: p‐aminobenzoic acid; DHF: dihydrofolate; THF: tetrahydrofolate; NADH: nicotinamide adenine dinucleotide; L‐ASP: L‐aspartic acid; β‐Ala: β‐alanine; CoA: co‐enzyme A; ATP: adenosine triphosphate. Created with Biorender.com.